Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06222268 · ClinicalTrials.gov registry record · Phase 1
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery
A Phase 1 study, sponsored by Wayne State University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 280
- Enrollment target
NCT06222268 is a Phase 1 study that has not yet begun recruiting, run by Wayne State University. The registered enrollment target is 280 participants.
The verdict
NCT06222268, a Phase 1 study, has not yet begun recruiting, sponsored by Wayne State University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 280 participants
- Enrollment target
Study Summary
The overall strategy is to recruit veterans with PTSD who report minimal current cannabis use but are interested in or considering therapeutic cannabis to manage mental health symptoms (anxiety, depression, PTSD and/or suicidality). The information gained from this study could lead to the development of new treatments for persons who suffer from post-traumatic stress disorder and maintain better mental health.
Interventions
- DRUG Placebo only
- DRUG Cannabidiol (CBD) only
- DRUG Delta-9-tetrahydrocannabinol (THC) only
- DRUG THC:CBD 1:1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2026-03 |
| Est. Completion | 2031-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06222268
The ClinicalTrials.gov registry entry for NCT06222268 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo only is the first listed.
NCT06222268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06222268 about?
NCT06222268 is a clinical study titled "Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery". The overall strategy is to recruit veterans with PTSD who report minimal current cannabis use but are interested in or considering therapeutic cannabis to manage mental health symptoms (anxiety, depression, PTSD and/or suicidality). The information gained from this study could lead to the developmen...
What is the current status of trial NCT06222268?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 280 participants. The study started on 2026-03. Estimated completion is 2031-09.
What interventions are being tested in trial NCT06222268?
The interventions under investigation include: Placebo only (DRUG), Cannabidiol (CBD) only (DRUG), Delta-9-tetrahydrocannabinol (THC) only (DRUG), THC:CBD 1:1 (DRUG).
Who is sponsoring clinical trial NCT06222268?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.